Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Mirai Bio provides access to end-to-end development capabilities with innovation at every step.
Extuitive is an AI-first business that aims to revolutionize the conception and validation of new consumer goods and creatives.
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.
Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics.
Metaphore Biotechnologies is a firm that uses biomimicry and machine learning to unlock the revolutionary therapeutic.
Serif Biomedicines is pioneering Modified DNA as a new type of biotechnology.
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.
Omega Therapeutics offers a proprietary epigenomic programming platform.
Terrana's innovative technology platform uses RNA-based plant health solutions to enable resilient agriculture for a world.
Etiome, a company redefining how we detect and preempt disease progression.
Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.
Lila Sciences creates a scientific superintelligence platform and autonomous labs for life sciences, chemistry, and materials science.
Quotient Therapeutics engages in transformative medicines made possible with somatic genomics.
Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Flagship Pioneering has invested in 70 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Flagship Pioneering's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Life Science. The firm invests across 16 different industry categories.
Among tracked funding rounds, Laronde received $440.0M in a Series B round. Flagship Pioneering's total known invested capital is $4.9B.
Flagship Pioneering's average investment size is $73.8M across its portfolio of 70 companies.
Recent Flagship Pioneering portfolio additions include Tarveda Therapeutics, Mirai Bio, Extuitive, Codiak Biosciences, Laronde. These companies were founded in 2020 or later.